Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03293758 · ClinicalTrials.gov registry record
Food and Microbiome Longitudinal Investigation (FAMiLI)
A clinical trial of Cancer and Cardiovascular Diseases, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 16,000
- Enrollment target
- 1
- Study location
NCT03293758 is a study of Cancer and Cardiovascular Diseases that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 16,000 participants, above the 3,465-participant average among 615 other Cancer trials with a reported enrollment target (362% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03293758, a study of Cancer and Cardiovascular Diseases, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 16,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The NYU Human Microbiome Study Cohort is designed to improve understanding of the role of human microbiome in health and disease. This study will serve as a critical NYU biorepository resource for research on human genetics and the microbiome in health and disease
Conditions Studied
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16,000 participants |
| Start Date | 2016-05-16 |
| Est. Completion | 2034-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03293758
The ClinicalTrials.gov registry entry for NCT03293758 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 16,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,465-participant average among 615 other Cancer trials with a reported enrollment target (362% higher). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03293758 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03293758 about?
NCT03293758 is a clinical study titled "Food and Microbiome Longitudinal Investigation (FAMiLI)". The NYU Human Microbiome Study Cohort is designed to improve understanding of the role of human microbiome in health and disease. This study will serve as a critical NYU biorepository resource for research on human genetics and the microbiome in health and disease
What is the current status of trial NCT03293758?
This trial is currently recruiting. The enrollment target is 16,000 participants. The study started on 2016-05-16. Estimated completion is 2034-12-31.
What conditions does trial NCT03293758 study?
This clinical trial studies the following conditions: Cancer, Cardiovascular Diseases.
Who is sponsoring clinical trial NCT03293758?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03293758 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.